187 related articles for article (PubMed ID: 10695817)
21. Cell-surface ganglioside GD2 in the immunohistochemical detection and differential diagnosis of neuroblastoma.
Sariola H; Terävä H; Rapola J; Saarinen UM
Am J Clin Pathol; 1991 Aug; 96(2):248-52. PubMed ID: 1713742
[TBL] [Abstract][Full Text] [Related]
22. Cytotoxicity of adriamycin-containing immunoliposomes targeted with anti-ganglioside monoclonal antibodies.
Ohta S; Igarashi S; Honda A; Sato S; Hanai N
Anticancer Res; 1993; 13(2):331-6. PubMed ID: 8517645
[TBL] [Abstract][Full Text] [Related]
23. Mast cell typing: demonstration of a distinct hematopoietic cell type and evidence for immunophenotypic relationship to mononuclear phagocytes.
Valent P; Ashman LK; Hinterberger W; Eckersberger F; Majdic O; Lechner K; Bettelheim P
Blood; 1989 May; 73(7):1778-85. PubMed ID: 2469499
[TBL] [Abstract][Full Text] [Related]
24. Functional analysis of four tetraspans, CD9, CD53, CD81, and CD82, suggests a common role in costimulation, cell adhesion, and migration: only CD9 upregulates HB-EGF activity.
Lagaudrière-Gesbert C; Le Naour F; Lebel-Binay S; Billard M; Lemichez E; Boquet P; Boucheix C; Conjeaud H; Rubinstein E
Cell Immunol; 1997 Dec; 182(2):105-12. PubMed ID: 9514697
[TBL] [Abstract][Full Text] [Related]
25. Detection of neuroblastoma cells in bone marrow using GD2 specific monoclonal antibodies.
Cheung NK; Von Hoff DD; Strandjord SE; Coccia PF
J Clin Oncol; 1986 Mar; 4(3):363-9. PubMed ID: 3081691
[TBL] [Abstract][Full Text] [Related]
26. Comparison of immunocytochemistry, real-time quantitative RT-PCR and flow cytometry for detection of minimal residual disease in neuroblastoma.
Ifversen MR; Kågedal B; Christensen LD; Rechnitzer C; Petersen BL; Heilmann C
Int J Oncol; 2005 Jul; 27(1):121-9. PubMed ID: 15942651
[TBL] [Abstract][Full Text] [Related]
27. Triggering of target of an antiproliferative antibody-1 (TAPA-1/CD81) up-regulates the release of tumour necrosis factor-alpha by the EBV-B lymphoblastoid cell line JY.
Altomonte M; Montagner R; Pucillo C; Maio M
Scand J Immunol; 1996 Apr; 43(4):367-73. PubMed ID: 8668914
[TBL] [Abstract][Full Text] [Related]
28. Flow cytometric detection of Ewing sarcoma cells in peripheral blood and bone marrow.
Dubois SG; Epling CL; Teague J; Matthay KK; Sinclair E
Pediatr Blood Cancer; 2010 Jan; 54(1):13-8. PubMed ID: 19711435
[TBL] [Abstract][Full Text] [Related]
29. A combination of CD15/CD10, CD64/CD33, CD16/CD13 or CD11b flow cytometric granulocyte panels is sensitive and specific for diagnosis of myelodysplastic syndrome.
Chung JW; Park CJ; Cha CH; Cho YU; Jang S; Chi HS; Seo EJ; Lee JH; Lee JH; Lee KH; Im HJ; Seo JJ
Ann Clin Lab Sci; 2012; 42(3):271-80. PubMed ID: 22964615
[TBL] [Abstract][Full Text] [Related]
30. Potential application of ELAVL4 real-time quantitative reverse transcription-PCR for detection of disseminated neuroblastoma cells.
Swerts K; De Moerloose B; Dhooge C; Vandesompele J; Hoyoux C; Beiske K; Benoit Y; Laureys G; Philippé J
Clin Chem; 2006 Mar; 52(3):438-45. PubMed ID: 16384890
[TBL] [Abstract][Full Text] [Related]
31. Determination of cell surface membrane antigens common to both human neuroblastoma and leukemia-lymphoma cell lines by a panel of 38 monoclonal antibodies.
Sugimoto T; Tatsumi E; Kemshead JT; Helson L; Green AA; Minowada J
J Natl Cancer Inst; 1984 Jul; 73(1):51-7. PubMed ID: 6610792
[TBL] [Abstract][Full Text] [Related]
32. Expression of markers shared between human haematopoietic cells and neuroblastoma cells.
Ebener U; Wehner S; Cinatl J; Gussetis ES; Kornhuber B
Anticancer Res; 1990; 10(4):887-90. PubMed ID: 2382985
[TBL] [Abstract][Full Text] [Related]
33. Anti-CD45 augments response of a Th2 clone to TCR cross-linking.
Wolff H; Janeway C
Scand J Immunol; 1994 Jul; 40(1):22-5. PubMed ID: 8029640
[TBL] [Abstract][Full Text] [Related]
34. Role of CD81 and CD58 in minimal residual disease detection in pediatric B lymphoblastic leukemia.
Tsitsikov E; Harris MH; Silverman LB; Sallan SE; Weinberg OK
Int J Lab Hematol; 2018 Jun; 40(3):343-351. PubMed ID: 29500862
[TBL] [Abstract][Full Text] [Related]
35. Expression of Disialoganglioside (GD2) in Neuroblastic Tumors: A Prognostic Value for Patients Treated With Anti-GD2 Immunotherapy.
Terzic T; Cordeau M; Herblot S; Teira P; Cournoyer S; Beaunoyer M; Peuchmaur M; Duval M; Sartelet H
Pediatr Dev Pathol; 2018; 21(4):355-362. PubMed ID: 29067879
[TBL] [Abstract][Full Text] [Related]
36. Monoclonal antibody B2, a marker of neuroendocrine sympathoadrenal precursors, recognizes the Luke (LKE) antigen.
Cooling L; Hwang D
Transfusion; 2005 May; 45(5):709-16. PubMed ID: 15847659
[TBL] [Abstract][Full Text] [Related]
37. Immunophenotypic characterization of normal and abnormal plasma cells in bone marrow of newly diagnosed multiple myeloma patients.
Awasthi NP; Mishra S; Gupta G; Kumari S; Bajpayee A; Singh P; Husain N
Indian J Pathol Microbiol; 2023; 66(2):295-300. PubMed ID: 37077071
[TBL] [Abstract][Full Text] [Related]
38. Detection of ganglioside GD2 in tumor tissues and sera of neuroblastoma patients.
Schulz G; Cheresh DA; Varki NM; Yu A; Staffileno LK; Reisfeld RA
Cancer Res; 1984 Dec; 44(12 Pt 1):5914-20. PubMed ID: 6498849
[TBL] [Abstract][Full Text] [Related]
39. Detection of neuroblastoma cells in bone marrow and peripheral blood by different techniques: accuracy and relationship with clinical features of patients.
Corrias MV; Faulkner LB; Pistorio A; Rosanda C; Callea F; Piccolo MS; Scaruffi P; Marchi C; Lacitignola L; Occhino M; Gambini C; Tonini GP; Haupt R; De Bernardi B; Pistoia V; Garaventa A
Clin Cancer Res; 2004 Dec; 10(23):7978-85. PubMed ID: 15585633
[TBL] [Abstract][Full Text] [Related]
40. Role of transmembrane 4 superfamily (TM4SF) proteins CD9 and CD81 in muscle cell fusion and myotube maintenance.
Tachibana I; Hemler ME
J Cell Biol; 1999 Aug; 146(4):893-904. PubMed ID: 10459022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
